Renal Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2023-08-03
  Clinical Trial Update: Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours [Phase 1, Phase 2]

  Phase 1/2 trial assessing stereotactic radiotherapy with pembrolizumab for oligometastatic renal cell carcinoma has completed with results p…

• CLINICAL_TRIALS trial_result · 2023-07-25
  Clinical Trial Update: Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma [Phase 2]

  Phase 2 trial update evaluating FolateScan to identify subjects with folate receptor-positive metastatic renal cell carcinoma; study complet…

• CLINICAL_TRIALS trial_result · 2023-06-22
  Clinical Trial Update: Safety and Efficacy of FolateScan (Technetium Tc 99m EC20) in Subjects With Suspected Metastatic Renal Cell Carcinoma [Phase 2]

  Phase 2 trial assessing safety and efficacy of FolateScan (Technetium Tc 99m EC20) in subjects with suspected metastatic renal cell carcinom…

• CLINICAL_TRIALS trial_result · 2023-06-15
  Clinical Trial Update: 68Ga-NY104 PET/CT Imaging in Renal Cell Carcinoma [Phase 2]

  Phase 2 clinical trial update for 68Ga-NY104 PET/CT imaging in renal cell carcinoma.

• CLINICAL_TRIALS trial_result · 2023-06-13
  Clinical Trial Update: Fluzoparib in Patients With Metastatic Non-clear Cell Renal Cell Carcinoma [Phase 2]

  Phase 2 clinical trial update for fluzoparib in patients with metastatic non-clear cell renal cell carcinoma has completed.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-06-01
  Clinical Trial Update: Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity [Phase 1, Phase 2]

  Clinical trial exploring risk factors of immune checkpoint inhibitor–mediated liver, GI, endocrine, and skin toxicity across early-phase tri…

• CLINICAL_TRIALS trial_result · 2023-04-19
  Clinical Trial Update: Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor [NA]

  Clinical trial evaluating a probiotic yogurt supplement to reduce diarrhea in patients with metastatic renal cell carcinoma treated with VEG…

• CLINICAL_TRIALS trial_result · 2023-04-11
  Clinical Trial Update: A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) [Phase 3]

  Phase 3 trial evaluating bempegaldesleukin (BEMPEG) plus nivolumab versus investigator's choice TKI therapy in advanced/metastatic renal cel…

• CLINICAL_TRIALS trial_result · 2023-03-29
  Clinical Trial Update: Denosumab and Pembrolizumab in Clear Cell Renal Carcinoma [Phase 2]

  Phase 2 trial investigating denosumab with pembrolizumab in clear cell renal cell carcinoma (metastatic).

• CLINICAL_TRIALS trial_result · 2023-03-21
  Clinical Trial Update: Study of Efficacy, Safety, and Quality of Life of Pazopanib in Patients With Advanced and/or Metastatic Renal Cell Carcinoma After Prior Checkpoint Inhibitor Treatment [Phase 2]

  Phase 2 trial evaluating pazopanib for efficacy, safety, and quality of life in patients with advanced or metastatic renal cell carcinoma af…

• CLINICAL_TRIALS trial_result · 2023-03-20
  Clinical Trial Update: CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma [Phase 2]

  Phase 2 trial comparing CB-839 with cabozantinib vs cabozantinib with placebo in metastatic renal cell carcinoma has completed with results …

• CLINICAL_TRIALS trial_result · 2023-03-13
  Clinical Trial Update: A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors [Phase 1, Phase 2]

  Phase 1/2 trial evaluating NKTR-214 in combination with nivolumab and other anti-cancer therapies in select advanced solid tumors completed …

• CLINICAL_TRIALS trial_result · 2023-03-08
  Clinical Trial Update: REVEAL Study of NKTR-262 in Combination With NKTR-214 and Nivolumab in Patients With Locally Advanced / Metastatic Solid Tumor Malignancies [Phase 1, Phase 2]

  Phase 1/2 trial REVEAL exploring NKTR-262 with NKTR-214 and nivolumab in various locally advanced/metastatic solid tumors was terminated; re…

• CLINICAL_TRIALS trial_result · 2023-03-08
  Clinical Trial Update: Immunological Variables Associated to ICI Toxicity in Cancer Patients [Phase 2]

  A Phase 2 clinical trial investigating immunological variables associated with immune checkpoint inhibitor toxicity in cancer patients.

• CLINICAL_TRIALS trial_result · 2023-02-02
  Clinical Trial Update: Mobile Intervention - Physical Activity in Cancer Treatment [NA]

  A terminated clinical trial investigating a mobile intervention to increase physical activity during cancer treatment; results posted in 202…

• CLINICAL_TRIALS trial_result · 2023-01-10
  Clinical Trial Update: A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma [Phase 2]

  Phase 2 trial update on retreatment with a combination of nivolumab and ipilimumab in advanced renal cell carcinoma; study terminated with p…

• CLINICAL_TRIALS trial_result · 2022-12-21
  Clinical Trial Update: Functional Microscale Organotypic Assays to Predict Patient Response to Anti-Angiogenesis Therapies [Phase 2]

  Phase 2 trial investigating functional microscale organotypic assays to predict patient response to anti-angiogenesis therapies in renal cel…

• CLINICAL_TRIALS trial_result · 2022-12-19
  Clinical Trial Update: A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma [Phase 2]

  Phase 2 trial update for combination treatments in advanced renal cell carcinoma has completed with posted results.

• CLINICAL_TRIALS trial_result · 2022-12-12
  Clinical Trial Update: GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors [Phase 1, Phase 2]

  Phase 1/2 safety trial of GEN1029 (HexaBody-DR5/DR5) in malignant solid tumors (termina ted; results posted in 2022).

• CLINICAL_TRIALS trial_result · 2022-11-18
  Clinical Trial Update: Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney [Phase 2]

  Phase 2 trial investigating focal ablative stereotactic radiosurgery for renal cell carcinoma.

• CLINICAL_TRIALS trial_result · 2022-11-09
  Clinical Trial Update: RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC) [Phase 2]

  Phase 2 clinical trial update for RAD001 in non-clear cell renal cell carcinoma has completed.

• CLINICAL_TRIALS trial_result · 2022-10-27
  Clinical Trial Update: A Study of Recombinant Vaccinia Virus in Combination With Cemiplimab for Renal Cell Carcinoma [Phase 1, Phase 2]

  A phase 1/2 clinical trial is evaluating recombinant vaccinia virus in combination with cemiplimab for renal cell carcinoma; the study is ac…

• CLINICAL_TRIALS trial_result · 2022-10-26
  Clinical Trial Update: Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors [Phase 1, Phase 2]

  Phase 1/2 trial evaluating aibrutinib combination therapy in selected gastrointestinal and genitourinary tumors has completed with results p…

• CLINICAL_TRIALS trial_result · 2022-10-06
  Clinical Trial Update: Tailored ImmunoTherapy Approach With Nivolumab in Subjects With Metastatic or Advanced Renal Cell Carcinoma [Phase 2]

  Phase 2 trial update evaluating a tailored immunotherapy approach with nivolumab in metastatic or advanced renal cell carcinoma.

• CLINICAL_TRIALS trial_result · 2022-09-21
  Clinical Trial Update: REduced Frequency ImmuNE Checkpoint Inhibition in Cancers [Phase 2]

  Phase 2 clinical trial update on reduced-frequency immune checkpoint inhibition in cancers including renal cell carcinoma and melanoma.